Literature DB >> 25943685

Calculating the Baseline Incidence in Patients Without Risk Factors: A Strategy for Economic Evaluation.

Scott D Nelson1, Daniel Malone, Joanne Lafleur.   

Abstract

Economic and epidemiological models need various inputs to estimate the occurrence of events in different subsets of the population, such as the incidence of events for patients with risk factors compared with those without. However, the baseline event incidence for patients without risk factors (incidence_no_risk) may not be reported in the literature, therefore the event incidence in the population (incidence_pop) is commonly used in its place as the baseline. However, this is problematic because incidence_pop is a weighted average of a heterogeneous population. We therefore developed a method for deriving the incidence for persons without risk factors (incidence_no_risk) by adjustment of incidence_pop. We calculated incidence_no_risk using the relative risk for events due to risk factors (RR_risk), incidence_pop, and the prevalence of the risk factor (pRF), which are typically available in the literature. Since the incidence for patient with risk factors (incidence_risk) can be expressed as incidence_risk = incidence_no_risk × RR_risk, we found that incidence_no_risk = incidence_pop/((RR_risk × pRF) + (1 - pRF)). We validated the equation by modeling the fracture incidence in high-risk patients in an osteoporosis transition-state model. With incidence_pop used as the baseline fracture incidence, the model overestimated hip fractures in the study population (10.72 fractures/1000 patient-years). After adjustment of incidence_pop using incidence_no_risk as the baseline incidence, the model accurately predicted hip fractures (2.27/1000 patient-years). Therefore, incidence_no_risk can be calculated using this method based on the event incidence for the study population, the relative risk increase associated with the risk factor, and the prevalence of the risk factor.

Entities:  

Mesh:

Year:  2015        PMID: 25943685     DOI: 10.1007/s40273-015-0283-x

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  19 in total

1.  United States life tables, 2007.

Authors:  Elizabeth Arias
Journal:  Natl Vital Stat Rep       Date:  2011-09-28

2.  Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.

Authors:  Margaret C Fang; Marcelo Coca Perraillon; Kaushik Ghosh; David M Cutler; Allison B Rosen
Journal:  Am J Med       Date:  2014-03-25       Impact factor: 4.965

3.  Clarifying differences in natural history between models of screening: the case of colorectal cancer.

Authors:  Marjolein van Ballegooijen; Carolyn M Rutter; Amy B Knudsen; Ann G Zauber; James E Savarino; Iris Lansdorp-Vogelaar; Rob Boer; Eric J Feuer; J Dik F Habbema; Karen M Kuntz
Journal:  Med Decis Making       Date:  2011-06-14       Impact factor: 2.583

4.  Cross-model comparisons to improve the value of modeling: the case of colorectal cancer screening.

Authors:  Michael Pignone; David F Ransohoff
Journal:  Med Decis Making       Date:  2011 Jul-Aug       Impact factor: 2.583

5.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

6.  Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.

Authors:  Kouta Ito; Victoria S Blinder; Elena B Elkin
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

7.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

8.  Using the osteoporosis self-assessment tool for referring older men for bone densitometry: a decision analysis.

Authors:  Kouta Ito; James P Hollenberg; Mary E Charlson
Journal:  J Am Geriatr Soc       Date:  2009-02       Impact factor: 5.562

9.  A meta-analysis of previous fracture and subsequent fracture risk.

Authors:  J A Kanis; O Johnell; C De Laet; H Johansson; A Oden; P Delmas; J Eisman; S Fujiwara; P Garnero; H Kroger; E V McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; A Silman; A Tenenhouse
Journal:  Bone       Date:  2004-08       Impact factor: 4.398

10.  Updated fracture incidence rates for the US version of FRAX.

Authors:  B Ettinger; D M Black; B Dawson-Hughes; A R Pressman; L J Melton
Journal:  Osteoporos Int       Date:  2009-08-25       Impact factor: 4.507

View more
  3 in total

1.  An evaluation of hospital admission respiratory disease attributed to sulfur dioxide ambient concentration in Ahvaz from 2011 through 2013.

Authors:  Gholamreza Goudarzi; Sahar Geravandi; Esmaeil Idani; Seyyed Ahmad Hosseini; Mohammad Mehdi Baneshi; Ahmad Reza Yari; Mehdi Vosoughi; Sina Dobaradaran; Saeed Shirali; Mohammad Bagherian Marzooni; Ali Ghomeishi; Nadali Alavi; Seyedeh Shaghayegh Alavi; Mohammad Javad Mohammadi
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-18       Impact factor: 4.223

2.  Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures.

Authors:  S D Nelson; R E Nelson; G W Cannon; P Lawrence; M J Battistone; M Grotzke; Y Rosenblum; J LaFleur
Journal:  Osteoporos Int       Date:  2014-07-19       Impact factor: 4.507

3.  Estimation of hospital admission respiratory disease cases attributed to exposure to SO2 and NO2 in two different sectors of Egypt.

Authors:  Atef Mf Mohammed; Yasser H Ibrahim; Inas A Saleh
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.